CDKN1A and ataxia telangiectasia: Unlike the Rieger et al (2004) study where microarray data on lymphoblastoid cells failed to predict toxicity in subjects with defined genetic defects like AT, the present results with CCNB1, CDKN1A and BBC3 clearly demonstrated differential responses between a healthy donor and an AT case.